¸®½ºÆä¸®µ·(Risperidone) ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : Åõ¿© °æ·Îº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Risperidone Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Route Of Administration, By Application, By End-Users, By Region, Competition, 2020-2030F
»óǰÄÚµå : 1668055
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,274,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,668,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,154,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸®½ºÆä¸®µ· ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 6,057¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 2030³â±îÁö CAGR 5.10%ÀÇ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¼¼°è ¸®½ºÆä¸®µ· ½ÃÀåÀº Á¤½ÅÁúȯÀÇ È¿°úÀûÀÎ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¿¡ ÈûÀÔ¾î Á¦¾à »ê¾÷ÀÇ Áß¿äÇÑ ºÎ¹®ÀÌ µÇ¾ú½À´Ï´Ù. Ç×Á¤½Åº´ ¾à¹°ÀÎ ¸®½ºÆä¸®µ·Àº Á¤½ÅºÐ¿­Áõ, ¾ç±Ø¼º Àå¾Ö, ƯÁ¤ ±âºÐÀå¾Ö µîÀÇ ÁúȯÀ» °ü¸®ÇÏ´Â µ¥ ÇÙ½ÉÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 6,057¾ï 5,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 8,183¾ï 2,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 5.10%
±Þ¼ºÀå ºÎ¹® °æ±¸
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ÃËÁø¿äÀÎ

Á¤½ÅÁúȯ À¯º´·ü Áõ°¡

ÁÖ¿ä ½ÃÀå °úÁ¦

±ÔÁ¦ À庮°ú ¾ÈÀü¿¡ ´ëÇÑ ¿ì·Á

ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¤½Å°Ç°­¿¡ ´ëÇÑ Àνİú Ä¡·á¿¡ ´ëÇÑ °ü½É Áõ°¡

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¸®½ºÆä¸®µ· ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ ¸®½ºÆä¸®µ· ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ ¸®½ºÆä¸®µ· ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¸®½ºÆä¸®µ· ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ ¸®½ºÆä¸®µ· ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸®½ºÆä¸®µ· ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå ¼¼°èÀÇ ¸®½ºÆä¸®µ· ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå Á¶»ç ȸ»ç ¼Ò°³ ¹× ¸éÃ¥»çÇ×

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Risperidone Market was valued at USD 605.75 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.10% through 2030. The global Risperidone market is a crucial segment of the pharmaceutical industry, driven by the demand for effective treatments of psychiatric disorders. Risperidone, an antipsychotic medication, plays a central role in managing conditions like schizophrenia, bipolar disorder, and certain mood disorders.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 605.75 Billion
Market Size 2030USD 818.32 Billion
CAGR 2025-20305.10%
Fastest Growing SegmentOral
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Mental Health Disorders

The rising prevalence of mental health disorders is a significant driver of the global Risperidone market, influencing demand, market expansion, and investment in mental health treatments. Risperidone, an antipsychotic medication primarily used to treat conditions such as schizophrenia, bipolar disorder, and irritability associated with autism, has seen increased adoption due to the growing burden of mental health issues worldwide. Mental health disorders, including schizophrenia, bipolar disorder, and autism spectrum disorders, are becoming more prevalent globally due to factors such as urbanization, lifestyle changes, stress, and greater awareness and diagnosis of these conditions. According to the World Health Organization (WHO), Approximately 1 in 4 of the global population will experience mental or neurological disorders at some stage in their lives. Currently, around 450 million individuals are affected by these conditions, making mental health disorders one of the primary contributors to ill-health and disability worldwide. Increased awareness campaigns and educational initiatives by governments, healthcare organizations, and advocacy groups have reduced the stigma surrounding mental health issues. As a result, more individuals are seeking diagnosis and treatment, leading to higher prescription rates of medications like Risperidone. This cultural shift has expanded the addressable market for antipsychotic drugs, driving growth in the Risperidone market.

Key Market Challenges

Regulatory Hurdles and Safety Concerns

The pharmaceutical industry operates within a heavily regulated framework, and Risperidone is no exception. Risperidone, like all medications, undergoes rigorous safety evaluations. Concerns about side effects, particularly metabolic and neurological issues, have led to increased scrutiny. Regulatory bodies often require pharmaceutical companies to update safety labels or provide additional warnings. As Risperidone loses patent protection in various regions, generic versions become available. Generic competition can lead to price erosion, reducing the revenue potential for branded Risperidone. These dynamic challenges market growth, as lower prices may affect profitability.

Key Market Trends

Increasing Focus on Mental Health Awareness and Treatment

Governments, international organizations, and healthcare advocacy groups have launched global mental health initiatives. These programs aim to raise awareness, reduce stigma, and improve access to mental health treatment. As a result, more individuals are seeking help for psychiatric disorders, driving the demand for medications like Risperidone. The integration of telehealth and digital mental health services has expanded access to psychiatric care. Remote consultations and telemedicine platforms facilitate diagnosis and treatment, including the prescription of Risperidone. This trend has gained further prominence during the COVID-19 pandemic. A shift towards community-based mental health services ensures that individuals have easier access to care. This trend promotes early diagnosis and treatment, leading to increased utilization of psychiatric medications like Risperidone.

Key Market Players

Report Scope:

In this report, the Global Risperidone Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Risperidone Market, By Route Of Administration:

Risperidone Market, By Application:

Risperidone Market, By End-Users:

Risperidone Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Risperidone Market.

Available Customizations:

Global Risperidone market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Risperidone Market Outlook

6. North America Risperidone Market Outlook

7. Europe Risperidone Market Outlook

8. Asia-Pacific Risperidone Market Outlook

9. South America Risperidone Market Outlook

10. Middle East and Africa Risperidone Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Risperidone Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â